Reviewing Green Organic Dutchman (OTCMKTS:TGODF) and Eisai (OTCMKTS:ESALY)

Earnings and Valuation

This table compares Green Organic Dutchman and Eisai”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Green Organic Dutchman	$24.13 million	0.00	-$33.62 million	($0.41)	N/A
Eisai	$6.74 billion	2.62	$426.79 million	$0.87	70.70

Eisai has higher revenue and earnings than Green Organic Dutchman. Green Organic Dutchman is trading at a lower price-to-earnings ratio than Eisai, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Green Organic Dutchman and Eisai’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Green Organic Dutchman	-83.86%	-22.02%	-14.58%
Eisai	4.11%	3.86%	2.50%

Volatility & Risk

Green Organic Dutchman has a beta of 2.27, suggesting that its stock price is 127% more volatile than the S&P 500. Comparatively, Eisai has a beta of 0.31, suggesting that its stock price is 69% less volatile than the S&P 500.

Institutional & Insider Ownership

0.4% of Green Organic Dutchman shares are held by institutional investors. Comparatively, 0.0% of Eisai shares are held by institutional investors. 8.7% of Green Organic Dutchman shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

Eisai beats Green Organic Dutchman on 7 of the 10 factors compared between the two stocks.

About Green Organic Dutchman

The Green Organic Dutchman Holdings Ltd. engages in the production, cultivation, processing, and distribution of cannabis and related products. Its products include cannabis plants, cannabis plant seeds, dried cannabis, fresh cannabis, cannabis oils, cannabis topicals, cannabis extracts, and edible cannabis. The company was founded by Scott Skinner and Jeannette VanderMarel in 2012 and is headquartered in Mississauga, Canada.

About Eisai

Eisai Co., Ltd. engages in the development, manufacture, and sale of prescription medicines and over-the-counter products. It operates through the Pharmaceutical Products Business and Other Business segments. The Pharmaceutical Products Business segment handles prescription and generic drugs, diagnostics, and consumer healthcare business in Japan, which manages over-the-counter drugs. The Other Business segment deals with food additives and chemicals. The company was founded by Toyoji Naito in November 1936 and is headquartered in Tokyo, Japan.